| Reviews |
 |
|
|
|
|
Reviews to:
Date: Tuesday, 24. November 2015
Author: Gast
Review:
this is be cool 8) pray jointly order eriacta pier Tecfidera, which is widely expected to become the No. 1 oraltreatment for the disease, with annual sales of more than $3billion, was launched in April. Biogen is expected to reportsales for the drug\'s first few weeks on the market on Thursday.
Evaluation:  |
|
|
|
| Shopping Cart |
 |
|
| You do not have any products in your shopping cart yet. |
|
|
Customer group:Guest
|
|
|
|
